Related Experiment Video

Updated: Aug 7, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Left ventricular assist system through the left ventricle for acute myocardial infarction: report of a case

Hiroki Hata1, Goro Matsumiya, Yoshiki Sawa

  • 1Division of Cardiovascular Surgery, Department of Surgery, Osaka University Graduate School of Medicine (E1), 2-2 Yamadaoka, Suita, Osaka, Japan.

Surgery Today
|June 24, 2006
PubMed

Insights

Early implantation of a left ventricular assist system effectively treated cardiogenic shock in a patient with acute myocardial infarction. This intervention supported the patient awaiting a heart transplant, highlighting its critical role in managing severe cardiac events.

Area of Science:

  • Cardiology
  • Mechanical Circulatory Support

Background:

  • Acute myocardial infarction (AMI) can lead to life-threatening cardiogenic shock.
  • Left main trunk occlusion is a severe cause of AMI.
  • Cardiogenic shock necessitates rapid and effective intervention to prevent multi-organ failure.

Observation:

  • A 49-year-old male patient experienced AMI due to left main trunk occlusion, progressing to cardiogenic shock.
  • A left ventricular assist system (LVAS) with apical drainage was implanted.
  • The patient has been supported by the LVAS for over 485 days while awaiting heart transplantation.

Findings:

  • Successful treatment of cardiogenic shock was achieved with LVAS implantation.
  • Timely LVAS application prevented the development of multiple organ failure.
  • LVAS provided sustained hemodynamic support in a complex cardiac patient.

Implications:

  • Left ventricular assist systems are effective in managing acute myocardial infarction with cardiogenic shock.
  • Early mechanical circulatory support can be a bridge to heart transplantation.
  • This case underscores the importance of prompt intervention in severe AMI cases.

More Related Videos

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Myocardial Infarction and Functional Outcome Assessment in Pigs12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...